Director Deals - (GSK)

Luke Miels, Chief Executive Officer, has re-invested 2,393 shares in the company on the 9th April 2026 at a price of £21.50. The Director now holds 1,480,419 shares.

Story provided by StockMarketWire.com

Director deals data provided by www.sharesmagazine.co.uk

< Back to list